DK1576967T3 - Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelse - Google Patents
Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelseInfo
- Publication number
- DK1576967T3 DK1576967T3 DK04290741T DK04290741T DK1576967T3 DK 1576967 T3 DK1576967 T3 DK 1576967T3 DK 04290741 T DK04290741 T DK 04290741T DK 04290741 T DK04290741 T DK 04290741T DK 1576967 T3 DK1576967 T3 DK 1576967T3
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- fragment
- adenylate cyclase
- recombinant protein
- therapeutic use
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04290741A EP1576967B1 (de) | 2004-03-18 | 2004-03-18 | Rekombinante Proteine, die Epitope des humanen Papillomavirus inseriert in einem Adenylatecyclase Protein oder in dessen Fragmenten tragen, und deren terapeutischen Verwendung. |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1576967T3 true DK1576967T3 (da) | 2008-01-21 |
Family
ID=34833798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK04290741T DK1576967T3 (da) | 2004-03-18 | 2004-03-18 | Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelse |
Country Status (19)
Country | Link |
---|---|
US (3) | US8628779B2 (de) |
EP (3) | EP1576967B1 (de) |
JP (2) | JP5438897B2 (de) |
KR (2) | KR101382250B1 (de) |
CN (1) | CN1956730B (de) |
AT (1) | ATE372784T1 (de) |
AU (1) | AU2005224036B2 (de) |
BR (1) | BRPI0508722A (de) |
CA (1) | CA2559235C (de) |
CY (1) | CY1107042T1 (de) |
DE (1) | DE602004008874T2 (de) |
DK (1) | DK1576967T3 (de) |
ES (1) | ES2293178T3 (de) |
MX (1) | MXPA06010469A (de) |
PL (1) | PL1576967T3 (de) |
PT (1) | PT1576967E (de) |
RU (1) | RU2441022C2 (de) |
SI (1) | SI1576967T1 (de) |
WO (1) | WO2005089792A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE438409T1 (de) | 2000-09-15 | 2009-08-15 | Pasteur Institut | Proteinhaltigen vektoren zur einführung von moleküle in cd11b exprimirende zellen |
ES2293178T3 (es) | 2004-03-18 | 2008-03-16 | Institut Pasteur | Proteina recombinante que contiene epitopos del papilomavirus humano insertados en un proteina adenilato ciclasa o un fragmento de la misma y usos terapeuticos de la misma. |
DK2656842T3 (en) * | 2006-03-27 | 2016-11-07 | Univ California | Androgen receptor MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND androgen receptor-ASSOCIATED DISEASES |
RU2448729C2 (ru) * | 2006-09-01 | 2012-04-27 | Жантисель | Композиции, вызывающие специфический ответ цитотоксических т-лимфоцитов, включающие лимфо-аблативное соединение и молекулу, содержащую антигенные последовательности и нацеленную на специализированные антиген-презентирующие клетки |
EP1894941A1 (de) * | 2006-09-01 | 2008-03-05 | Institut Pasteur | Behandlung von Gebärmutterhalskarzinomen mit einer rekombinanten Adenylat-Cyclase die HPV-Antigene trägt |
CA3167595A1 (en) * | 2007-05-31 | 2008-12-04 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines |
ES2331271B1 (es) * | 2007-06-29 | 2010-10-14 | Universidad Del Pais Vasco | Metodo para la internalizacion de bacterias no invasivas en celulas eucariotas. |
CA2694457A1 (en) * | 2007-07-24 | 2009-01-29 | Ingrid Jolanda Monique De Vries | Compositions and methods for generating an immune response in a subject |
JP5770711B2 (ja) * | 2009-03-23 | 2015-08-26 | アンスティテュ パストゥール | 細胞中への免疫原性分子のデリバリーに適したCyaAポリペプチド突然変異体及びポリペプチド誘導体 |
ES2655687T3 (es) * | 2009-09-11 | 2018-02-21 | Proyecto De Biomedicina Cima, S.L. | Composiciones terapéuticas para el tratamiento de enfermedades causadas por HPV |
MX2013000584A (es) * | 2010-07-15 | 2013-09-26 | British Columbia Cancer Agency | Composiciones de antigeno e7 de virus de papiloma humano y usos de las mismas. |
EP2478915A1 (de) | 2011-01-24 | 2012-07-25 | Genticel | cyaA-getragene Polypeptid(e) und Verwendung zur Induzierung von therapeutischen und prophylaktischen Immunantworten |
PL2729158T3 (pl) | 2011-06-17 | 2018-07-31 | Universiteit Gent | Szczepionki przeciwko Chlamydia |
US9901635B2 (en) | 2011-12-21 | 2018-02-27 | Vaccibody As | Vaccines against HPV |
EP2687849A1 (de) * | 2012-07-20 | 2014-01-22 | ISA Pharmaceuticals B.V | Verfahren zur Bereitstellung einer optimierten Immuntherapiezusammensetzung |
EP2690172A1 (de) | 2012-07-23 | 2014-01-29 | Genticel | CYAA-basierte chimäre Proteine mit einem heterologen Polypeptid und deren Verwendungen bei der Induktion von Immunreaktionen |
EP2689786A1 (de) * | 2012-07-23 | 2014-01-29 | Genticel | HPV/CYAA-basierte chimäre Proteine und deren Verwendungen bei der Induktion von Immunreaktionen gegen eine HPV-Infektion und HPV-induzierter Störungen |
EP3030900A2 (de) | 2013-08-08 | 2016-06-15 | Institut Pasteur | Korrelation von erkrankungsaktivitäten mit klonalen expansionen menschlicher papillomavirus 16-spezifischer cd8+-t-zellen bei patienten mit schwerem erosivem oralem lichen planus |
EP2975120A1 (de) * | 2014-07-17 | 2016-01-20 | Institut Pasteur | Monomeres und funktionelles Adenylatcyclase-CyaA-Toxin |
WO2016077382A2 (en) | 2014-11-11 | 2016-05-19 | Massachusetts Eye & Ear Infirmary | Conjunctivitis vaccines |
EP3037103A1 (de) | 2014-12-23 | 2016-06-29 | Genticel | Immunotherapeutischer Impfstoff mit E7-Proteinen von HPV16 und HPV18 fusioniert mit CyaA zur Verwendung bei mit HIV infizierten Personen |
SG11201707540QA (en) * | 2015-03-16 | 2017-10-30 | Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft | Method of detecting new immunogenic t cell epitopes and isolating new antigen-specific t cell receptors by means of an mhc cell library |
WO2017211886A1 (en) * | 2016-06-07 | 2017-12-14 | Deutsches Krebsforschungszentrum | Improvement of hpv l2 peptide immunogenicity |
WO2018091613A1 (en) | 2016-11-17 | 2018-05-24 | Ecole Nationale Vétérinaire de Toulouse | Immunogenic and vaccine compositions for use against bordetella bronchiseptica infection |
EP3323426A1 (de) | 2016-11-17 | 2018-05-23 | Ecole Nationale Vétérinaire de Toulouse | Immunogen- und impfstoffzusammensetzungen zur verwendung gegen bordetella-bronchiseptica-infektion |
EP3342421A1 (de) | 2016-12-27 | 2018-07-04 | Genticel | Immunogene zusammensetzung mit cyaa-abgeleitetem polypeptid, das eine th1/th17-orientierte immunreaktion fördert |
CN112423783A (zh) * | 2018-05-30 | 2021-02-26 | 德国癌症研究中心 | 组合的预防性和治疗性疫苗 |
WO2021063917A1 (en) | 2019-10-01 | 2021-04-08 | Universiteit Gent | Vaccine against chlamydia in swine |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4015044A1 (de) * | 1990-05-10 | 1991-11-14 | Behringwerke Ag | Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18 |
SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay |
US6183745B1 (en) * | 1990-12-12 | 2001-02-06 | The University Of Queensland | Subunit papilloma virus vaccine and peptides for use therein |
DK0637335T3 (da) * | 1992-04-21 | 2007-11-26 | Pasteur Institut | Rekombinante mutanter til induktion af specifikke immunreaktioner |
ATE438409T1 (de) * | 2000-09-15 | 2009-08-15 | Pasteur Institut | Proteinhaltigen vektoren zur einführung von moleküle in cd11b exprimirende zellen |
CN1561389A (zh) * | 2001-07-25 | 2005-01-05 | 纽约大学 | 糖基神经酰胺作为用于抗传染病和癌症的疫苗的佐剂的用途 |
EP1489092A1 (de) | 2003-06-18 | 2004-12-22 | Institut Pasteur | Modifizierte Bordetella Adenylatcyclase mit oder ohne CD11b/CD18 Interaktionsdomäne und seine Verwendungen |
CA2546452C (en) * | 2003-11-21 | 2015-01-20 | Institut Pasteur | Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
ES2293178T3 (es) * | 2004-03-18 | 2008-03-16 | Institut Pasteur | Proteina recombinante que contiene epitopos del papilomavirus humano insertados en un proteina adenilato ciclasa o un fragmento de la misma y usos terapeuticos de la misma. |
EP1894941A1 (de) * | 2006-09-01 | 2008-03-05 | Institut Pasteur | Behandlung von Gebärmutterhalskarzinomen mit einer rekombinanten Adenylat-Cyclase die HPV-Antigene trägt |
ES2505324T3 (es) | 2009-03-23 | 2014-10-09 | Institut Pasteur | Polipéptidos de CyaA mutantes y derivados polipeptídicos adecuados para el suministro de moléculas inmunogénicas a una célula |
-
2004
- 2004-03-18 ES ES04290741T patent/ES2293178T3/es not_active Expired - Lifetime
- 2004-03-18 PL PL04290741T patent/PL1576967T3/pl unknown
- 2004-03-18 DK DK04290741T patent/DK1576967T3/da active
- 2004-03-18 EP EP04290741A patent/EP1576967B1/de not_active Expired - Lifetime
- 2004-03-18 DE DE602004008874T patent/DE602004008874T2/de not_active Expired - Lifetime
- 2004-03-18 SI SI200430519T patent/SI1576967T1/sl unknown
- 2004-03-18 AT AT04290741T patent/ATE372784T1/de active
- 2004-03-18 PT PT04290741T patent/PT1576967E/pt unknown
-
2005
- 2005-03-18 KR KR1020067021582A patent/KR101382250B1/ko active IP Right Grant
- 2005-03-18 AU AU2005224036A patent/AU2005224036B2/en active Active
- 2005-03-18 MX MXPA06010469A patent/MXPA06010469A/es active IP Right Grant
- 2005-03-18 EP EP05728249.3A patent/EP1725259B1/de active Active
- 2005-03-18 JP JP2007503308A patent/JP5438897B2/ja active Active
- 2005-03-18 WO PCT/EP2005/003452 patent/WO2005089792A1/en active Application Filing
- 2005-03-18 CN CN2005800087095A patent/CN1956730B/zh active Active
- 2005-03-18 CA CA2559235A patent/CA2559235C/en active Active
- 2005-03-18 RU RU2006131598/10A patent/RU2441022C2/ru active
- 2005-03-18 EP EP10181329.3A patent/EP2351580B1/de active Active
- 2005-03-18 BR BRPI0508722-8A patent/BRPI0508722A/pt not_active Application Discontinuation
- 2005-03-18 KR KR1020137016447A patent/KR101495740B1/ko active IP Right Grant
-
2006
- 2006-09-08 US US11/517,313 patent/US8628779B2/en active Active
-
2007
- 2007-11-29 CY CY20071101529T patent/CY1107042T1/el unknown
-
2010
- 2010-12-23 US US12/977,754 patent/US8637039B2/en active Active
-
2013
- 2013-05-21 JP JP2013107236A patent/JP5824474B2/ja active Active
- 2013-12-16 US US14/106,921 patent/US9387243B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1576967T3 (da) | Rekombinant protein, der bærer epitoper fra det humane papillomvirus indsat i et adenylatcyclaseprotein eller et fragment deraf samt dets terapeutiske anvendelse | |
WO2008026071A3 (en) | Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying hpv antigens | |
HUP0500345A2 (hu) | Készítmények és alkalmazások tüdőrák kezelésére és diagnosztizálására | |
TW200608993A (en) | Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface | |
WO2005012350A3 (en) | Epha2 t-cell epitope agonists and uses therefor | |
CY1118200T1 (el) | Πολυπεπτιδια, πολυνουκλεοτιδια και συνθεσεις για χρηση στη θεραπεια λανθανουσας φυματιωσης | |
BRPI0606790A2 (pt) | anticorpo humano isolado ou porção de ligação de antìgeno do mesmo, polipeptìdeo isolado, composição, ácido nucleico isolado, vetor de expressão célula hospedeira, vacina contra a raiva, kit, uso de um anticorpo monoclonal humano isolado ou porção de ligação de antìgeno do mesmo, ou de uma quantidade eficaz de uma composição, método para identificar um anticorpo ou um fragmento do mesmo, anticorpo ou fragmento do mesmo, anticorpo ou fragmento do mesmo,e, glicoproteìna. | |
WO2005012337A3 (en) | Antigenic peptides of sars coronavirus and uses thereof | |
WO2010074575A3 (en) | Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. | |
NZ593289A (en) | Anti-neuropilin-1 antibodies for treating angiogenesis | |
NO20065366L (no) | Antistoffer og molekyler som er avledet fra disse som binder til STEAP-1-proteiner | |
NO20062916L (no) | Overflatelokaliserte campylobacter jejuni-polypeptider | |
DE602004018141D1 (de) | Polypeptide mit bindungsaffinität für her2 | |
ATE556717T1 (de) | Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus | |
PE20090690A1 (es) | Mutaciones de k-ras y b-raf y terapia con anticuerpos anti-egfr | |
MX2010002716A (es) | Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago. | |
WO2004111081A3 (en) | Antigenic peptides of sars coronavirus and uses thereof | |
WO2008012362A3 (en) | New protein isoforms and uses thereof | |
MX2009010492A (es) | Elementos de vector de expresion recombinante (reves) para mejorar la expresion de proteinas recombinantes en celulas huesped. | |
MX2009013824A (es) | Proteinas de enlace de antigeno que enlazan par-2. | |
BRPI0906997A2 (pt) | Proteína, uso da proteína combinante ou fragmento da mesma, método para induzir uma resposta imune em um individuo, método para tratar um paceinte, construção de ácido nicleico, vetor de ezpressão o ucélula hospedeira, vacina, anticorpo, e, composição farmaceutica | |
NO20071789L (no) | Fremgangsmate for anvendelse av dodsreseptorligander og CD20-antistoffer | |
PE20141565A1 (es) | Metodos para detectar papilomavirus humano y proporcionar pronostico para carcinoma de celulas escamosas de cabeza y cuello | |
BRPI0607692A2 (pt) | peptìdeos para detecção de anticorpo para o vìrus da sìndrome reprodutiva e respiratória suìna | |
UA90493C2 (ru) | Альфа-тимозиновые пептиды как адьюванты противораковых вакцин |